Vaxcell-Bio Therapeutics Co., Ltd.

Vaxcell-Bio Therapeutics Co., Ltd.

323990.KQ
Vaxcell-Bio Therapeutics Co., Ltd.KR flagKOSDAQ
4,420.00
KRW
-120.00
- -
102.43BMarket Cap

Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) Stock Split History

Learn about Vaxcell-Bio Therapeutics Co., Ltd.'s most recent 6-for-5 basis stock split on November 10, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Vaxcell-Bio Therapeutics Co., Ltd.'s most recent stock split

Split Date: 2023-11-10
Split Ratio: 6:5
Price Before Split: $25500.00
Price After Split: $21250.00

Developer API

Get 323990.KQ split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/323990.KQ

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.20 times more shares (a 6:5 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Vaxcell-Bio Therapeutics Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-11-106:5No$25500.00$21250.00
2020-12-302:1No$334600.01$167300.00

About Vaxcell-Bio Therapeutics Co., Ltd.

Company overview and industry information

Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) operates in the Biotechnology industry. The recent 6-for-5 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Vaxcell-Bio Therapeutics Co., Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.